Efstathiou A, Vlachveis M, Tsonis G, Asteri T, Psarakis A, Fessatidis I T
Cardiothoracic Surgery Department, George Papanikolaou General Regional Hospital, Exohi, Thessaloniki, Greece.
J Cardiovasc Surg (Torino). 2003 Apr;44(2):197-204.
We examined the impact of leukocyte filtration during the entire bypass time on postoperative leukocytosis, perioperative hemorrhage and overall clinical outcome in patients undergoing elective cardiac surgery.
Eighty patients who electively underwent cardiac surgery were randomly allocated to a leukocyte depletion group (n=40) or a control group (n=40). In patients of the leukocyte depletion group an arterial line filter with leukocyte depleting capacity (Pall LG6) was applied instead of a standard arterial line filter. White blood cells and platelet count were estimated preoperatively and at various times postoperatively. Postoperative clinical outcomes were also recorded.
Repeated measure analysis of variance between groups showed that leukocyte counts were significantly lower in the depletion group postoperatively (p=0.005) whereas no difference was found in the platelet counts (p=0.37). The catecholamine dose required at the time of weaning from cardiopulmonary bypass and during the first 12 postoperative hours was found to be lower in the leukodepletion group (p=0.027 and p=0.021, respectively). Furthermore leukodepleted patients showed a transient improvement in the oxygenation index (p=0.029) and a shorter period of mechanical ventilation (p<0.001). The incidences of postoperative complications were similar between the groups. No difference was observed in regard to postoperative blood loss (p=0.821) and amount of packed red blood cells required for transfusion during the first 24 hours (p=0.846). The duration of intensive care unit stay and of hospitalization were similar between the groups.
Leukocyte depletion contributes to early postoperative improvement in heart and lung function but does not influence significantly the overall clinical outcome of patients undergoing elective cardiac surgery.
我们研究了在整个体外循环期间进行白细胞滤过对择期心脏手术患者术后白细胞增多、围手术期出血及总体临床结局的影响。
80例择期行心脏手术的患者被随机分为白细胞清除组(n = 40)和对照组(n = 40)。白细胞清除组患者使用具有白细胞清除能力的动脉滤器(颇尔LG6)代替标准动脉滤器。术前及术后不同时间点评估白细胞和血小板计数。同时记录术后临床结局。
组间重复测量方差分析显示,术后白细胞清除组白细胞计数显著降低(p = 0.005),而血小板计数无差异(p = 0.37)。发现白细胞清除组在体外循环撤机时及术后最初12小时所需的儿茶酚胺剂量较低(分别为p = 0.027和p = 0.021)。此外,白细胞清除的患者氧合指数有短暂改善(p = 0.029),机械通气时间较短(p < 0.001)。两组术后并发症发生率相似。术后失血量(p = 0.821)及术后24小时内所需浓缩红细胞输注量(p = 0.846)无差异。两组重症监护病房住院时间及住院时间相似。
白细胞清除有助于择期心脏手术患者术后早期心肺功能改善,但对总体临床结局无显著影响。